SciELO - Scientific Electronic Library Online

 
vol.26 número2Abordagem de proctite rádica grave com ablação por radiofrequênciaNódulo do Septo Rectovaginal: A Chave para um Diagnóstico Inesperado índice de autoresíndice de assuntosPesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


GE-Portuguese Journal of Gastroenterology

versão impressa ISSN 2341-4545

GE Port J Gastroenterol vol.26 no.2 Lisboa abr. 2019

https://doi.org/10.1159/000487550 

ENDOSCOPIC SNAPSHOT

 

Endoscopic Resection of a Rectal Neuroendocrine Tumor: Hybrid Endoscopic Submucosal Dissection

Resseção endoscópica de um tumor neuroendócrino do recto: disseção submucosa endoscópica híbrida

 

Marta Gravito-Soaresa,c, Elisa Gravito-Soaresa,c, Pedro Amaroa, Inês Cunhaa, João Fragab, Luís Toméa,c

aGastroenterology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; bPathology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; cFaculty of Medicine, University of Coimbra, Coimbra, Portugal

* Corresponding author.

 

Keywords: Hybrid endoscopic submucosal dissection, Neuroendocrine tumor, Rectum

Palavras-Chave: Disseção submucosa endoscópica híbrida, Tumor neuroendócrino, Recto

 

A 67-year-old man was referred to our institution due to a 10-mm yellowish subepithelial lesion in the middle rectum incidentally diagnosed during screening colonoscopy. Conventional biopsies showed a well-differentiated neuroendocrine tumor (NET). Abdominopelvic computed tomography and endoscopic ultrasound showed limited submucosal invasion and no locoregional/distant metastasis. It was decided to perform a hybrid endoscopic submucosal dissection (ESD) technique. First, submucosal injection was performed using methylene-blue-stained saline containing 1: 100,000 epinephrine with adequate lesion lifting; second, a circumferential incision with a 1–2 mm free margin (ERBE VIO 300D: Endocut I, effect-1) was made using a ClearCut knife 2 mm I-type (Finemedix, South Korea); third, a partial submucosal dissection was done, using the same knife and settings; and fourth, an en bloc resection with an oval 15-mm diathermic snare (Olympus, Spain) was performed (Forced Coag, effect-2 80 W) without complications and resection time of 9 min (Fig. 1a–f). Histopathology showed a 9-mm NET G1 (WHO classification, 0 mitoses/10 HPF, Ki-67: 1.8%; pT1a AJCC stage 1), limited to the submucosa with free lateral (1.0 mm) and deep (0.6 mm) resection margins (Fig. 2a–g). Considering R0 resection of a < 10-mm rectal NET (R-NET), no followup was scheduled.

 

 

 

Despite the increasing incidence due to the widespread use of screening colonoscopy, R-NET are relatively rare and often well differentiated [1–5]. Endoscopic resection plays a central role in the resection of small well-differentiated R-NET (< 10 mm) and selected cases measuring 10–20 mm, given the low risk of metastasis [2–4]. There is no consensus regarding the best endoscopic resection technique [1, 2, 4, 5], including conventional polypectomy, endoscopic mucosal resection (EMR) or ESD. Conventional polypectomy should be avoided as complete resection is often not achieved [1, 4] and EMR shows a suboptimal complete resection rate (30–70%) due to frequent submucosal involvement affecting mostly the vertical margin [1, 3, 5]. Incomplete resection requires endoscopic retreatment with additional difficulty due to submucosal fibrosis, surgery and/or long-term follow-up. Alternatively, ESD has a higher complete resection rate (80– 100%) with the disadvantage of being a complex and time-consuming procedure and an increased risk of complications [1–4].

Recently, modified EMR (cap- or band ligation-assisted), hybrid EMR/ESD (H-EMR/ESD) techniques, and full-thickness resection [1, 3–5] have been proposed to improve in-depth resection of conventional EMR and decrease ESD drawbacks [3–5]. These techniques have a comparable complete resection rate (70–100%) and similar safety profile as ESD, but with a shorter procedure time [1–4]. H-EMR/ESD has an additional advantage for difficult lesions and tumor size close to 10 mm or larger, reducing recurrence rate related with modified-EMR due to the limited tumor size that can be aspirated [2, 5]. However, there are no randomized trials comparing these different resection techniques.

Although ESD, modified EMR, and H-EMR/ESD could be adequate in this case, considering the pericentimetric endoscopic size of the lesion, the authors opted to perform an H-EMR/ESD in order to secure horizontal free margin. Partial submucosal dissection after complete circumferential incision was additionally performed to provide a deeper submucosal resection and more precise snaring beneath the lesion, theoretically increasing the vertical tumor-free margin without the risk of a full dissection. H-EMR/ESD may be a good treatment choice for small R-NET limited to submucosa, without significantly compromising the completeness, timing, and safety of the procedure.

 

References

1 Chablaney S, Zator ZA, Kumta NA: Diagnosis and management of rectal neuroendocrine tumors. Clin Endosc 2017;50:530–536.         [ Links ]

2 He L, Deng T, Luo H: Efficacy and safety of endoscopic resection therapies for rectal carcinoid tumors: a meta-analysis. Yonsei Med J 2015;56:72–81.         [ Links ]

3 Park SB, Kim HW, Kang DH, et al: Advantage of endoscopic mucosal resection with a cap for rectal neuroendocrine tumors. World J Gastroenterol 2015;21:9387–9393.         [ Links ]

4 Bang BW, Park JS, Kim HK, et al: Endoscopic resection for small rectal neuroendocrine tumors: comparison of endoscopic submucosal resection with band ligation and endoscopic submucosal dissection. Gastroenterol Res Pract 2016;2016:6198927.         [ Links ]

5 Zhang J, Liu M, Li H, et al: Comparison of endoscopic therapies for rectal carcinoid tumors: endoscopic mucosal resection with circumferential incision versus endoscopic submucosal dissection. Clin Res Hepatol Gastroenterol 2018;42:24–30.         [ Links ]

 

Statement of Ethics

Protection of human and animal subjects: The authors declare that no experiments were performed on humans or animals for this study. Confidentiality of data: The authors declare that they have followed the protocols of their work center on the publication of patient data. Right to privacy: The authors declare that no patient data appear in this article. Informed patient consent for publication: Informed consent was obtained for this case report.

Disclosure Statement

The authors declare no disclosures to report.

 

* Corresponding author.

Dr. Marta Gravito-Soares

Gastroenterology Department, Centro Hospitalar e Universitário de Coimbra

Praceta Prof. Mota Pinto PT–3000-075 Coimbra (Portugal)

E-Mail ms18498@gmail.com

 

Received: December 11, 2017; Accepted after revision: February 7, 2018

 

Author Contributions

Marta Gravito-Soares and Elisa Gravito-Soares contributed equally, writing the manuscript and reviewing the literature. Marta Gravito-Soares is the article guarantor. João Fraga reviewed histologic findings. Pedro Amaro, Inês Cunha, and Luís Tomé contributed to critical revision of the manuscript for important intellectual content.

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons